Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Longitudinal Differences By Treatment Arm in Health-Related Quality of Life Among High Risk Pediatric Hodgkin's Lymphoma Patients Treated on the Children's Oncology Group Ahod 1331 Study

Annalynn M Williams, Angie Mae Rodday, Qinglin Pei, Tara O. Henderson, Frank Keller, Angela Punnett, Kara M. Kelly, Sharon M. Castellino, Susan K Parsons

Blood (2023) 142 (Supplement 1): 672.

https://doi.org/10.1182/blood-2023-187125

Published: 2023

Journal Articles

Improved Neurocognitive Outcomes with Contemporary Treatments in Survivors of Early Adolescent and Young Adult Hematologic Malignancies from the Childhood Cancer Survivor Study

Amy Yuan Wang, Annalynn M Williams, Yan Chen, Yutaka Yasui, Wendy Stock, Wendy Leisenring, Gregory Armstrong, Kevin Oeffinger, Eric J. Chow, Kevin R. Krull, Tara O. Henderson

Blood (2023) 142 (Supplement 1): 3776.

https://doi.org/10.1182/blood-2023-182329

Published: 2023

Journal Articles

AHOD2131: A Randomized Phase 3 Response-Adapted Trial Comparing Standard Therapy with Immuno-Oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma

Blood (2023) 142 (Supplement 1): 3084.

https://doi.org/10.1182/blood-2023-189652

Published: 2023

Journal Articles

New Onset Neurocognitive Impairment in Long-Term Survivors of Early Adolescent and Young Adult Hematologic Malignancies: A Report from the Childhood Cancer Survivor Study

Amy Yuan Wang, Annalynn M Williams, Yan Chen, Yutaka Yasui, Wendy Stock, Wendy Leisenring, Gregory Armstrong, Kevin Oeffinger, Eric J. Chow, Kevin R. Krull, Tara O. Henderson

Blood (2023) 142 (Supplement 1): 670.

https://doi.org/10.1182/blood-2023-182160

Published: 2023

Journal Articles

Peripheral Neuropathy in Children with High Risk Hodgkin Lymphoma (HL): The Role of Protocol-Stipulated Dose Modification in the Children's Oncology Group (COG) AHOD1331 Study

Susan K. Parsons, Frank G. Keller, Qinglin Pei, Angie Mae Rodday, Jennifer Belsky, Yue Wu, Angela Punnett, Tara O Henderson, Kara M. Kelly, Sharon M. Castellino

Blood (2022) 140 (Supplement 1): 6550–6551.

https://doi.org/10.1182/blood-2022-167046

Published: 2022

Journal Articles

Adverse Childhood Experiences (ACEs) in Newly-Diagnosed Childhood and Adolescent/Young Adult (AYA) Cancer Patients with Hematologic Malignancies

Lindsay F Schwartz, Marcia M Tan, Julie S McCrae, Tiffany Burkhardt, Kirsten K. Ness, Tara O Henderson

Blood (2021) 138 (Supplement 1): 4108.

https://doi.org/10.1182/blood-2021-144481

Published: 2021

Journal Articles

Survival Varies By Age and Histology in Classical Hodgkin Lymphoma: A Report from the Children's Oncology Group

Justine M. Kahn, MDMSc, Kara M. Kelly, MD, Qinglin Pei, PhD, Yue Wu, MS, Debra L. Friedman, MD, Tara O. Henderson, MD MPH, David C. Hodgson, MD MPH, FRCPC, Joel A. Kaplan, DO, MPH, Frank G. Keller, MD, Smita Bhatia, MDMPH, Cindy L. Schwartz, MD, Sharon M. Castellino, MD MSc

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-138796

Published: 2020

Journal Articles

Low-Dose Tamoxifen (LDTam) As a Breast Cancer (BC) Risk-Reduction Strategy in Lymphoma Survivors Exposed to Chest Radiation Therapy (RT) during Adolescence/Young Adulthood - a Randomized, Placebo-Controlled Double Blinded Phase IIb Trial

Blood (2019) 134 (Supplement_1): 2843.

https://doi.org/10.1182/blood-2019-126661

Published: 2019

Journal Articles

Productivity Loss Among Parent Caregivers Is Associated with Poor Health-Related Quality of Life (HRQL) at the Intial Diagnosis of Pediatric Advanced Stage Hodgkin Lymphoma (HL)

Susan K Parsons, MD MRP, Sharon M. Castellino, MD MSc, Angie Mae Rodday, PhD, Frank G Keller, MD, Kara M. Kelly, MD, Rena M Conti, PhD, Debra Lerner, PhD MSc, Tara O. Henderson, MDMPH

Blood (2018) 132 (Supplement 1): 975.

https://doi.org/10.1182/blood-2018-99-117316

Published: 2018

Journal Articles

Health-Related Quality of Life (HRQL) Trajectories during Treatment for Advanced Stage Pediatric Hodgkin Lymphoma (HL)

Susan K Parsons, MD MRP, Angie Mae Rodday, PhD MS, Rizvan Bush, MS, Qinglin Pei, PhD, Anem Waheed, MD MPH, Frank G Keller, MD, Kara M. Kelly, MD, Tara O. Henderson, MD MPH, Sharon M. Castellino, MD MSc

Blood (2018) 132 (Supplement 1): 3587.

https://doi.org/10.1182/blood-2018-99-112664

Published: 2018

Journal Articles

Survival By Race/Ethnicity in Children and Adolescents with Hodgkin Lymphoma Treated on Cooperative Group Trials in the U.S. and Canada: A Pooled Analysis of Children's Oncology Group Trials

Justine M. Kahn, MD, Kara M. Kelly, MD, Qinglin Pei, PhD, Debra L. Friedman, MD, Frank Keller, MD, Rizvan Bush, MS, Smita Bhatia, MDMPH, Tara O. Henderson, MD MPH, Cindy L. Schwartz, MD, Sharon M. Castellino, MD MSc

Blood (2017) 130 (Supplement 1): 607.

https://doi.org/10.1182/blood.V130.Suppl_1.607.607

Published: 2017

Journal Articles

Approach and Feasibility of Patient-Reported Outcomes (PROs) in a Phase III Clinical Trial for Advanced Stage Classical Hodgkin Lymphoma (cHL) in Children and Adolescents

Tara O Henderson, MDMPH, Sharon M Castellino, MD, Frank G Keller, MD, Kara M. Kelly, MD, Rachael Curtis, Rena M Conti, PhD, Susan K Parsons, MDMRP

Blood (2016) 128 (22): 3583.

https://doi.org/10.1182/blood.V128.22.3583.3583

Published: 2016

Journal Articles

The Affordable Care Act Improves Healthcare Access and Utilization Among Young Adults with Sickle Cell Disease

Wendy Darlington, MD MAPP, Sydeaka P Watson, PhD, Tara O Henderson, MD MPH, John M Cunningham, MD, Rena M Conti, PhD

Blood (2016) 128 (22): 4747.

https://doi.org/10.1182/blood.V128.22.4747.4747

Published: 2016

Journal Articles

Cognitive, Behavior and Academic Problems in Adolescent Survivors of Childhood Acute Lymphoblastic Leukemia (ALL): A Report from the Childhood Cancer Survivor Study

Lisa M Jacola, PhD, Kim Edelstein, PhD CPsych, Wei Liu, PhD, Ching-Hon Pui, MD, Robert J. Hayashi, MD, Nina Kadan-Lottick, MD MSPH, Deokumar Srivastava, PhD, Tara O Henderson, MDMPH, Leslie L. Robison, PhD MPH, Gregory T. Armstrong, MD MSCE, Kevin R. Krull, PhD

Blood (2015) 126 (23): 877.

https://doi.org/10.1182/blood.V126.23.877.877

Published: 2015

Journal Articles

An Adjustable Markov Model to Project Life Expectancy (LE) for Early Stage Favorable Risk Hodgkin Lymphoma Patients Treated with Contemporary Therapy

Michael J. Kelly, MD MPH, MS, Susan K Parsons, MDMRP, David C. Hodgson, MD, Joshua T Cohen, PhD, Jennifer M Yeh, MD PhD, Jeremy S. Abramson, MD, Debra L. Friedman, MD MS, Tara O Henderson, MDMPH, Peter W Johnson, MD, Stephen G Pauker, MD, John M. Raemaekers, MD PhD, Jane N. Winter, MD, Kara M. Kelly, MD, Ralph M. Meyer, MD, Sharon M Castellino, MD, Andrew M. Evens, DO, MSc

Blood (2015) 126 (23): 2635.

https://doi.org/10.1182/blood.V126.23.2635.2635

Published: 2015

Journal Articles

Outcomes in Adolescents and Young Adults (AYA) with Hodgkin Lymphoma (HL) Treated on US Cooperative Group Protocols: An Adult Intergroup (E2496) and Children's Oncology Group (COG AHOD0031) Comparative Analysis

Blood (2015) 126 (23): 2636.

https://doi.org/10.1182/blood.V126.23.2636.2636

Published: 2015

NARROW

Longitudinal Differences By Treatment Arm in Health-Related Quality of Life Among High Risk Pediatric Hodgkin's Lymphoma Patients Treated on the Children's Oncology Group Ahod 1331 Study

Improved Neurocognitive Outcomes with Contemporary Treatments in Survivors of Early Adolescent and Young Adult Hematologic Malignancies from the Childhood Cancer Survivor Study

AHOD2131: A Randomized Phase 3 Response-Adapted Trial Comparing Standard Therapy with Immuno-Oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma

New Onset Neurocognitive Impairment in Long-Term Survivors of Early Adolescent and Young Adult Hematologic Malignancies: A Report from the Childhood Cancer Survivor Study

Peripheral Neuropathy in Children with High Risk Hodgkin Lymphoma (HL): The Role of Protocol-Stipulated Dose Modification in the Children's Oncology Group (COG) AHOD1331 Study

Adverse Childhood Experiences (ACEs) in Newly-Diagnosed Childhood and Adolescent/Young Adult (AYA) Cancer Patients with Hematologic Malignancies

Survival Varies By Age and Histology in Classical Hodgkin Lymphoma: A Report from the Children's Oncology Group

Low-Dose Tamoxifen (LDTam) As a Breast Cancer (BC) Risk-Reduction Strategy in Lymphoma Survivors Exposed to Chest Radiation Therapy (RT) during Adolescence/Young Adulthood - a Randomized, Placebo-Controlled Double Blinded Phase IIb Trial

Productivity Loss Among Parent Caregivers Is Associated with Poor Health-Related Quality of Life (HRQL) at the Intial Diagnosis of Pediatric Advanced Stage Hodgkin Lymphoma (HL)

Health-Related Quality of Life (HRQL) Trajectories during Treatment for Advanced Stage Pediatric Hodgkin Lymphoma (HL)

Survival By Race/Ethnicity in Children and Adolescents with Hodgkin Lymphoma Treated on Cooperative Group Trials in the U.S. and Canada: A Pooled Analysis of Children's Oncology Group Trials

Approach and Feasibility of Patient-Reported Outcomes (PROs) in a Phase III Clinical Trial for Advanced Stage Classical Hodgkin Lymphoma (cHL) in Children and Adolescents

The Affordable Care Act Improves Healthcare Access and Utilization Among Young Adults with Sickle Cell Disease

Cognitive, Behavior and Academic Problems in Adolescent Survivors of Childhood Acute Lymphoblastic Leukemia (ALL): A Report from the Childhood Cancer Survivor Study

An Adjustable Markov Model to Project Life Expectancy (LE) for Early Stage Favorable Risk Hodgkin Lymphoma Patients Treated with Contemporary Therapy

Outcomes in Adolescents and Young Adults (AYA) with Hodgkin Lymphoma (HL) Treated on US Cooperative Group Protocols: An Adult Intergroup (E2496) and Children's Oncology Group (COG AHOD0031) Comparative Analysis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only